# A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea

> **NCT01074307** · PHASE4 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 180 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** Low Dose Bisoprolol
- **DRUG:** High Dose Bisoprolol

## Key facts

- **NCT ID:** NCT01074307
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2014-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01074307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01074307, "A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01074307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*